| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | PDCD1 | Synonyms | CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q37.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | programmed cell death 1 | ||||
| GTO ID | GTC2245 |
| Trial ID | NCT04162119 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|PD1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/PD1 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | Safety and Efficiency Study of BCMA-PD1-cells in Relapsed/Refractory Multiple Myeloma |
| Year | 2019 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | HNYY-XYK-01 |
| Cohort 1 | |||||||
|
|||||||